JPH07121852B2 - Cosmetics - Google Patents
CosmeticsInfo
- Publication number
- JPH07121852B2 JPH07121852B2 JP61053372A JP5337286A JPH07121852B2 JP H07121852 B2 JPH07121852 B2 JP H07121852B2 JP 61053372 A JP61053372 A JP 61053372A JP 5337286 A JP5337286 A JP 5337286A JP H07121852 B2 JPH07121852 B2 JP H07121852B2
- Authority
- JP
- Japan
- Prior art keywords
- sodium
- chloride
- dihydrogen phosphate
- potassium
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000002537 cosmetic Substances 0.000 title claims description 25
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 32
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 claims description 30
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 claims description 30
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 claims description 28
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims description 26
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 22
- 235000002639 sodium chloride Nutrition 0.000 claims description 21
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 16
- 239000001110 calcium chloride Substances 0.000 claims description 16
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 16
- 235000011148 calcium chloride Nutrition 0.000 claims description 16
- 239000011780 sodium chloride Substances 0.000 claims description 16
- 239000001103 potassium chloride Substances 0.000 claims description 15
- 235000011164 potassium chloride Nutrition 0.000 claims description 15
- 239000012266 salt solution Substances 0.000 claims description 15
- 235000017557 sodium bicarbonate Nutrition 0.000 claims description 15
- 229910000030 sodium bicarbonate Inorganic materials 0.000 claims description 15
- 229910001629 magnesium chloride Inorganic materials 0.000 claims description 14
- 235000011147 magnesium chloride Nutrition 0.000 claims description 14
- 235000019799 monosodium phosphate Nutrition 0.000 claims description 14
- 229910000403 monosodium phosphate Inorganic materials 0.000 claims description 14
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims description 13
- 235000019341 magnesium sulphate Nutrition 0.000 claims description 13
- 229910000402 monopotassium phosphate Inorganic materials 0.000 claims description 13
- 235000019796 monopotassium phosphate Nutrition 0.000 claims description 13
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 claims description 13
- 229920002683 Glycosaminoglycan Polymers 0.000 claims description 12
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 claims description 11
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 11
- 229930003427 Vitamin E Natural products 0.000 claims description 10
- 239000011709 vitamin E Substances 0.000 claims description 10
- 229940046009 vitamin E Drugs 0.000 claims description 10
- 235000019165 vitamin E Nutrition 0.000 claims description 10
- 229910017053 inorganic salt Inorganic materials 0.000 claims description 9
- 150000004347 all-trans-retinol derivatives Chemical class 0.000 claims description 4
- XONPDZSGENTBNJ-UHFFFAOYSA-N molecular hydrogen;sodium Chemical compound [Na].[H][H] XONPDZSGENTBNJ-UHFFFAOYSA-N 0.000 claims description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims 1
- 210000003491 skin Anatomy 0.000 description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 14
- 230000000694 effects Effects 0.000 description 12
- 230000003020 moisturizing effect Effects 0.000 description 12
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 12
- 239000006210 lotion Substances 0.000 description 9
- 238000011156 evaluation Methods 0.000 description 8
- 210000000434 stratum corneum Anatomy 0.000 description 8
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 235000019441 ethanol Nutrition 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 239000002304 perfume Substances 0.000 description 3
- 230000002633 protecting effect Effects 0.000 description 3
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 3
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 3
- 229960000984 tocofersolan Drugs 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 2
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 229920000045 Dermatan sulfate Polymers 0.000 description 2
- 206010013786 Dry skin Diseases 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 239000004909 Moisturizer Substances 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 229960000458 allantoin Drugs 0.000 description 2
- 229940087168 alpha tocopherol Drugs 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- KXKPYJOVDUMHGS-OSRGNVMNSA-N chondroitin sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](OS(O)(=O)=O)[C@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](C(O)=O)O1 KXKPYJOVDUMHGS-OSRGNVMNSA-N 0.000 description 2
- VFNGKCDDZUSWLR-UHFFFAOYSA-L disulfate(2-) Chemical compound [O-]S(=O)(=O)OS([O-])(=O)=O VFNGKCDDZUSWLR-UHFFFAOYSA-L 0.000 description 2
- 230000037336 dry skin Effects 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 229920002674 hyaluronan Polymers 0.000 description 2
- 229960003160 hyaluronic acid Drugs 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000001333 moisturizer Effects 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- 239000001540 sodium lactate Substances 0.000 description 2
- 235000011088 sodium lactate Nutrition 0.000 description 2
- 229940005581 sodium lactate Drugs 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- 235000014692 zinc oxide Nutrition 0.000 description 2
- CPYIZQLXMGRKSW-UHFFFAOYSA-N zinc;iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+3].[Fe+3].[Zn+2] CPYIZQLXMGRKSW-UHFFFAOYSA-N 0.000 description 2
- 239000002076 α-tocopherol Substances 0.000 description 2
- 235000004835 α-tocopherol Nutrition 0.000 description 2
- WGVKWNUPNGFDFJ-DQCZWYHMSA-N β-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C WGVKWNUPNGFDFJ-DQCZWYHMSA-N 0.000 description 2
- OEANUJAFZLQYOD-CXAZCLJRSA-N (2r,3s,4r,5r,6r)-6-[(2r,3r,4r,5r,6r)-5-acetamido-3-hydroxy-2-(hydroxymethyl)-6-methoxyoxan-4-yl]oxy-4,5-dihydroxy-3-methoxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](OC)O[C@H](CO)[C@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](OC)[C@H](C(O)=O)O1 OEANUJAFZLQYOD-CXAZCLJRSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 229920002567 Chondroitin Polymers 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 description 1
- 239000011627 DL-alpha-tocopherol Substances 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 241000208690 Hamamelis Species 0.000 description 1
- 229920002971 Heparan sulfate Polymers 0.000 description 1
- 229920000288 Keratan sulfate Polymers 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-L Phosphate ion(2-) Chemical compound OP([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-L 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- MSCCTZZBYHQMQJ-AZAGJHQNSA-N Tocopheryl nicotinate Chemical compound C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OC(=O)C1=CC=CN=C1 MSCCTZZBYHQMQJ-AZAGJHQNSA-N 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 1
- 229940066595 beta tocopherol Drugs 0.000 description 1
- 229940105847 calamine Drugs 0.000 description 1
- 239000008338 calamine lotion Substances 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 description 1
- 229940094517 chondroitin 4-sulfate Drugs 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- AVJBPWGFOQAPRH-FWMKGIEWSA-L dermatan sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@H](OS([O-])(=O)=O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](C([O-])=O)O1 AVJBPWGFOQAPRH-FWMKGIEWSA-L 0.000 description 1
- 229940051593 dermatan sulfate Drugs 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-M dihydrogenphosphate Chemical compound OP(O)([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-M 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 235000010382 gamma-tocopherol Nutrition 0.000 description 1
- 229960005150 glycerol Drugs 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036074 healthy skin Effects 0.000 description 1
- 229910052864 hemimorphite Inorganic materials 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- KXCLCNHUUKTANI-RBIYJLQWSA-N keratan Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@H](COS(O)(=O)=O)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@H](O[C@@H](O[C@H]3[C@H]([C@@H](COS(O)(=O)=O)O[C@@H](O)[C@@H]3O)O)[C@H](NC(C)=O)[C@H]2O)COS(O)(=O)=O)O[C@H](COS(O)(=O)=O)[C@@H]1O KXCLCNHUUKTANI-RBIYJLQWSA-N 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 231100000989 no adverse effect Toxicity 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 235000007686 potassium Nutrition 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 229940079889 pyrrolidonecarboxylic acid Drugs 0.000 description 1
- 230000001932 seasonal effect Effects 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 235000015424 sodium Nutrition 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 229950009883 tocopheryl nicotinate Drugs 0.000 description 1
- 235000007680 β-tocopherol Nutrition 0.000 description 1
- 239000011590 β-tocopherol Substances 0.000 description 1
- 239000002478 γ-tocopherol Substances 0.000 description 1
- QUEDXNHFTDJVIY-DQCZWYHMSA-N γ-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-DQCZWYHMSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/007—Preparations for dry skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Description
【発明の詳細な説明】 [産業上の利用分野] 本発明は、新規な化粧料に関し、さらに詳しくは、ムコ
多糖類と、ビタミンE類と、塩化ナトリウム、塩化カリ
ウム、塩化カルシウム、塩化マグネシウム、硫酸マグネ
シウム、炭酸水素ナトリウム、リン酸水素二ナトリウ
ム、リン酸二水素ナトリウム、リン酸二水素カリウムか
ら選択される生理的塩類溶液を構成する混合無機塩とを
必須に含有することを特徴とする化粧料に関するもので
ある。TECHNICAL FIELD The present invention relates to a novel cosmetic, more specifically, mucopolysaccharide, vitamin E, sodium chloride, potassium chloride, calcium chloride, magnesium chloride, Cosmetics characterized by essentially containing a mixed inorganic salt constituting a physiological salt solution selected from magnesium sulfate, sodium hydrogen carbonate, disodium hydrogen phosphate, sodium dihydrogen phosphate and potassium dihydrogen phosphate. It is about fees.
本発明の目的とするところは、皮膚の乾燥、肌荒れを防
止し、皮膚に弾力性、柔軟性を賦与する、保湿効果並び
に皮膚の保護効果の優れた化粧料を提供することにあ
る。An object of the present invention is to provide a cosmetic composition which prevents dryness and rough skin, and imparts elasticity and flexibility to the skin, which is excellent in a moisturizing effect and a skin protecting effect.
[従来の技術] 皮膚における保湿のメカニズムについては、複雑な因子
が絡む為、未だ不明な点が多く残されているが、その中
で各角質層の水分量は、角質層がその形態・機能を維持
する為の重要な因子であり、健康な皮膚の角質層におい
ては、体内外からの水分供給と皮膚からの水分蒸発との
バランスによって適度の水分量が保たれている。しか
し、皮脂分泌の少ない乾燥肌の人や、季節の変化等でこ
のバランスが崩れた場合には、角質層の水分量が減少し
て皮膚がかさつき、極端な場合にはひびやあかぎれを生
ずることがある。[Prior Art] Regarding the moisturizing mechanism in the skin, there are still many unclear points because complicated factors are involved, but among them, the water content of each stratum corneum depends on the shape and function of the stratum corneum. It is an important factor for maintaining a proper amount of water, and in the stratum corneum of healthy skin, an appropriate amount of water is maintained by the balance between water supply from inside and outside the body and water evaporation from the skin. However, if this balance is lost due to dry skin with less sebum secretion or due to seasonal changes, the water content of the stratum corneum decreases and the skin becomes bulky, and in extreme cases cracks and cracks occur. Sometimes.
このような観点から、一般に、角質層の水分量を保つ為
に、グリセリン、ピロリドンカルボン酸ナトリウム、乳
酸ナトリウム等の保湿剤を配合した化粧料が用いられて
きた。From this point of view, generally, cosmetics containing a humectant such as glycerin, sodium pyrrolidonecarboxylate, and sodium lactate have been used in order to maintain the water content of the stratum corneum.
また、従来、ムコ多糖類、アラントイン、コラーゲン
や、種々の植物抽出物等を、肌荒れ防止、創傷治癒等の
効果を有するとして、化粧料に配合する試みがなされて
きた(特開昭57−183707、60−116619他)。Further, conventionally, attempts have been made to incorporate mucopolysaccharides, allantoin, collagen, various plant extracts and the like into cosmetics as having effects of preventing rough skin, healing wounds, etc. (JP-A-57-183707). , 60-116619 and others).
一方、ビタミンE類は、古くからその酸化防止効果が注
目され、抗酸化剤等として化粧品に配合されてきた。On the other hand, vitamin Es have long been attracting attention for their antioxidant effect, and have been blended in cosmetics as antioxidants and the like.
[発明が解決しようとする問題点] しかしながら、いわゆる保湿剤は、水分を角質層に供給
するという機能は有するが、一時的な効果しかなく、し
かも低湿度環境下では、逆に角質層から水分を奪うとい
う欠点を有している。[Problems to be Solved by the Invention] However, a so-called moisturizer has a function of supplying water to the stratum corneum, but has only a temporary effect, and, in a low humidity environment, conversely, moisture is removed from the stratum corneum. It has the drawback of taking away.
また、ムコ多糖類、アラントイン、コラーゲンや、植物
抽出物等は、前記の如く優れた美容効果を有するもので
あるが、未だ満足すべき保湿効果を有するものが得られ
ておらず、種々研究されているのが現状である。Further, mucopolysaccharides, allantoin, collagen and plant extracts have excellent cosmetic effects as described above, but those having a satisfactory moisturizing effect have not yet been obtained, and various studies have been conducted. Is the current situation.
[問題点を解決する為の手段] 本発明者等は、係る点に鑑み、優れた保湿効果を有する
化粧料を得るべく鋭意研究した結果、ムコ多糖類と、ビ
タミンE類と塩化ナトリウム、塩化カリウム、塩化カル
シウム、塩化マグネシウム、硫酸マグネシウム、炭酸水
素ナトリウム、リン酸水素二ナトリウム、リン酸二水素
ナトリウム、リン酸二水素カリウムから選択される生理
的塩類溶液を構成する混合無機塩とを必須に配合するこ
とにより、極めて顕著な保湿効果が得られることを見出
し、本発明を完成するに到った。[Means for Solving Problems] In view of the above points, the present inventors have earnestly studied to obtain a cosmetic having an excellent moisturizing effect, and as a result, mucopolysaccharide, vitamin Es, sodium chloride, and chloride. Essentially a mixed inorganic salt that constitutes a physiological salt solution selected from potassium, calcium chloride, magnesium chloride, magnesium sulfate, sodium hydrogen carbonate, disodium hydrogen phosphate, sodium dihydrogen phosphate, and potassium dihydrogen phosphate. It has been found that a very remarkable moisturizing effect can be obtained by blending, and the present invention has been completed.
すなわち、本発明は、ムコ多糖及び/又はその誘導体
と、ビタミンE及び/又はその誘導体と、塩化ナトリウ
ム、塩化カリウム、塩化カルシウム、塩化マグネシウ
ム、硫酸マグネシウム、炭酸水素ナトリウム、リン酸水
素二ナトリウム、リン酸二水素ナトリウム、リン酸二水
素カリウムから選択される生理的塩類溶液を構成する混
合無機塩とを必須に含有することを特徴とし、保湿効果
に優れ、また皮膚の保護効果を有する化粧料を提供する
ものである。That is, the present invention provides a mucopolysaccharide and / or a derivative thereof, a vitamin E and / or a derivative thereof, sodium chloride, potassium chloride, calcium chloride, magnesium chloride, magnesium sulfate, sodium hydrogencarbonate, disodium hydrogenphosphate and phosphorus. Sodium dihydrogen acid, potassium dihydrogen phosphate, a mixture of inorganic salts constituting a physiological salt solution is essential, characterized by containing a cosmetic, excellent in moisturizing effect, also having a skin protection effect It is provided.
本発明において使用されるムコ多糖及び/又はその誘導
体としては、ヒアルロン酸、ヒアルロン酸−蛋白複合
体、コンドロイチン4硫酸、コンドロイチン6硫酸、コ
ンドロイチン4,6ジ硫酸、デルマタン硫酸、デルマタン
4,6ジ硫酸、ケラタン硫酸、ヘパラン硫酸、キチン等
と、これらの塩類並びに誘導体が挙げられる。ムコ多糖
類は皮膚の構成成分の一種であり、動物由来、微生物由
来、合成品の何れでも用い得る。すなわち、起源や抽出
方法、精製処理方法は特に限定されるものではない。Examples of the mucopolysaccharide and / or its derivative used in the present invention include hyaluronic acid, hyaluronic acid-protein complex, chondroitin 4 sulfate, chondroitin 6 sulfate, chondroitin 4,6 disulfate, dermatan sulfate, and dermatan.
Examples thereof include 4,6 disulfate, keratan sulfate, heparan sulfate, chitin, and salts and derivatives thereof. Mucopolysaccharide is one of the constituents of the skin and may be derived from animals, microorganisms or synthetic products. That is, the origin, extraction method, and purification treatment method are not particularly limited.
化粧料中におけるムコ多糖及び/又はその誘導体の配合
量は、少なすぎる場合は効果がなく、0.0001〜5.0重量
%の範囲が使用感上も好ましく、本発明の目的の為には
十分であるが、0.001〜3.0重量%の範囲であればより好
ましい。When the amount of the mucopolysaccharide and / or its derivative in the cosmetic is too small, there is no effect, and a range of 0.0001 to 5.0% by weight is preferable in terms of usability, and is sufficient for the purpose of the present invention. , 0.001 to 3.0% by weight is more preferable.
また、本発明において使用されるビタミンE及び/又は
その誘導体としては、天然ビタミンE、α−トコフェロ
ール、β−トコフェロール、γ−トコフェロール、δ−
トコフェロール等のビタミンEと、酢酸トコフェロー
ル、ニコチン酸トコフェロール等の誘導体が挙げられ
る。In addition, as vitamin E and / or its derivative used in the present invention, natural vitamin E, α-tocopherol, β-tocopherol, γ-tocopherol, δ-
Examples thereof include vitamin E such as tocopherol, and derivatives such as tocopherol acetate and tocopherol nicotinate.
化粧料中におけるビタミンE及び/又はその誘導体の配
合量は0.0001〜5.0重量%の範囲が本発明にとって効果
的であるが、0.001〜2.0重量%の範囲であればより好ま
しい。The amount of vitamin E and / or its derivative in the cosmetic is 0.0001 to 5.0% by weight, which is effective for the present invention, but 0.001 to 2.0% by weight is more preferable.
さらに本発明において必須に配合される生理的塩類溶液
を構成する混合無機塩は、生理的に許容される塩類であ
り、塩化ナトリウム、塩化カリウム、塩化カルシウム、
塩化マグネシウム、硫酸マグネシウム、炭酸水素ナトリ
ウム、リン酸水素二ナトリウム、リン酸二水素ナトリウ
ム、リン酸二水素カリウムから選択されるものである。Furthermore, the mixed inorganic salts constituting the physiological salt solution essential to the present invention are physiologically acceptable salts, such as sodium chloride, potassium chloride, calcium chloride,
It is selected from magnesium chloride, magnesium sulfate, sodium hydrogen carbonate, disodium hydrogen phosphate, sodium dihydrogen phosphate and potassium dihydrogen phosphate.
化粧料中における塩化ナトリウム、塩化カリウム、塩化
カルシウム、塩化マグネシウム、硫酸マグネシウム、炭
酸水素ナトリウム、リン酸水素二ナトリウム、リン酸二
水素ナトリウム、リン酸二水素カリウムから選択される
生理的塩類溶液を構成する混合無機塩の配合量は0.01〜
5.0重量%の範囲とするのが効果的であり、かつ化粧料
中の他成分との相互作用による悪影響等もなく、好まし
い。また、上記塩化ナトリウム、塩化カリウム、塩化カ
ルシウム、塩化マグネシウム、硫酸マグネシウム、炭酸
水素ナトリウム、リン酸水素二ナトリウム、リン酸二水
素ナトリウム、リン酸二水素カリウムから選択される生
理的塩類溶液を構成する混合無機塩の他に、通常生理的
塩類溶液の成分として用いられるグルコース等の他の成
分を配合することも、本発明の効果を妨げるものではな
い。Consists of a physiological salt solution selected from sodium chloride, potassium chloride, calcium chloride, magnesium chloride, magnesium sulfate, sodium hydrogen carbonate, disodium hydrogen phosphate, sodium dihydrogen phosphate, potassium dihydrogen phosphate in cosmetics The blending amount of the mixed inorganic salt is 0.01 to
The range of 5.0% by weight is effective, and there is no adverse effect due to interaction with other components in the cosmetic, which is preferable. Further, it constitutes a physiological salt solution selected from the above-mentioned sodium chloride, potassium chloride, calcium chloride, magnesium chloride, magnesium sulfate, sodium hydrogen carbonate, disodium hydrogen phosphate, sodium dihydrogen phosphate, potassium dihydrogen phosphate. In addition to the mixed inorganic salt, the addition of other components such as glucose, which are usually used as components of physiological salt solutions, does not hinder the effects of the present invention.
上記塩化ナトリウム、塩化カリウム、塩化カルシウム、
塩化マグネシウム、硫酸マグネシウム、炭酸水素ナトリ
ウム、リン酸水素二ナトリウム、リン酸二水素ナトリウ
ム、リン酸二水素カリウムから選択される生理的塩類溶
液を構成する混合無機塩の化粧料への配合の際には、塩
化ナトリウム、塩化カリウム、塩化カルシウム、塩化マ
グネシウム、硫酸マグネシウム、炭酸水素ナトリウム、
リン酸水素二ナトリウム、リン酸二水素ナトリウム、リ
ン酸二水素カリウムから選択される生理的塩類溶液を構
成する混合無機塩を、個々に配合しても、また、予め精
製水に溶解させたものを調製して配合しても良く、配合
方法は特に限定しない。上記塩化ナトリウム、塩化カリ
ウム、塩化カルシウム、塩化マグネシウム、硫酸マグネ
シウム、炭酸水素ナトリウム、リン酸水素二ナトリウ
ム、リン酸二水素ナトリウム、リン酸二水素カリウムか
ら選択される生理的塩類溶液を構成する混合無機塩の溶
液のpHは、4.0〜8.0の範囲とするのが、肌への刺激等も
なく、適当である。Sodium chloride, potassium chloride, calcium chloride,
When blending a mixed inorganic salt that constitutes a physiological salt solution selected from magnesium chloride, magnesium sulfate, sodium hydrogen carbonate, disodium hydrogen phosphate, sodium dihydrogen phosphate, and potassium dihydrogen phosphate into cosmetics Is sodium chloride, potassium chloride, calcium chloride, magnesium chloride, magnesium sulfate, sodium hydrogen carbonate,
A mixed inorganic salt that constitutes a physiological salt solution selected from disodium hydrogen phosphate, sodium dihydrogen phosphate, and potassium dihydrogen phosphate, individually blended or dissolved in purified water in advance. May be prepared and blended, and the blending method is not particularly limited. A mixed inorganic that constitutes a physiological salt solution selected from the above sodium chloride, potassium chloride, calcium chloride, magnesium chloride, magnesium sulfate, sodium hydrogen carbonate, disodium hydrogen phosphate, sodium dihydrogen phosphate, and potassium dihydrogen phosphate. It is appropriate that the pH of the salt solution is in the range of 4.0 to 8.0, since it does not cause irritation to the skin.
本発明の化粧料は、上記の如くムコ多糖及び/又はその
誘導体と、ビタミンE及び/又はその誘導体と、塩化ナ
トリウム、塩化カリウム、塩化カルシウム、塩化マグネ
シウム、硫酸マグネシウム、炭酸水素ナトリウム、リン
酸水素二ナトリウム、リン酸二水素ナトリウム、リン酸
二水素カリウムから選択される生理的塩類溶液を構成す
る混合無機塩とを必須に含有することを特徴とするもの
であるが、これに加えて、通常化粧料に用いられる界面
活性剤、油分、保湿剤、紫外線吸収剤、アルコール類、
キレート剤、pH調整剤、防腐剤、増粘剤、色素、香料等
を必要に応じ適宜配合し得る。As described above, the cosmetic of the present invention comprises a mucopolysaccharide and / or a derivative thereof, vitamin E and / or a derivative thereof, sodium chloride, potassium chloride, calcium chloride, magnesium chloride, magnesium sulfate, sodium hydrogen carbonate, hydrogen phosphate. It is characterized in that it essentially contains a mixed inorganic salt constituting a physiological salt solution selected from disodium, sodium dihydrogen phosphate, and potassium dihydrogen phosphate, but in addition to this, usually Surfactants, oils, moisturizers, UV absorbers, alcohols used in cosmetics,
A chelating agent, a pH adjuster, an antiseptic, a thickener, a dye, a fragrance and the like may be appropriately added as needed.
本発明でいう化粧料とは、皮膚の保護を目的とした化粧
料であり、特にスキンローション、カラミンローショ
ン、アストリンゼントローション、ヘアローション、ボ
ディローション等の水性化粧料として用いられるもので
ある。The cosmetics referred to in the present invention are cosmetics for the purpose of protecting the skin, and are particularly used as water-based cosmetics such as skin lotions, calamine lotions, astringent lotions, hair lotions and body lotions.
[実施例] 次に、本発明について、実施例を挙げてさらに説明す
る。これらは本発明を何ら限定するものではない。EXAMPLES Next, the present invention will be further described with reference to examples. These do not limit the invention in any way.
まず、表1に処方を示す実施例[1]及び比較例[1]
〜[7]の8種の試料(化粧水)を、通常の方法で調製
し、保湿効果の測定及び官能検査を行って、その効果を
比較した。First, Table 1 shows the formulations [1] and Comparative Examples [1].
Eight types of samples (lotion) of [7] to [7] were prepared by a usual method, the moisturizing effect was measured, and the sensory test was performed to compare the effects.
なお、表中の値は重量%を示す。The values in the table show% by weight.
i) 保湿効果の測定 20〜40才の女性20名を被験者とし、左右前腕屈側部各4
箇所を試験部位として、各試験部位に、各サンプルを1
日に朝、晩2回塗布した。なお、使用期間は冬期の2週
間とした。 i) Measurement of moisturizing effect Twenty women aged 20 to 40 were used as subjects, and each of the left and right forearm flexion lateral parts 4
1 sample for each test site
It was applied twice a day, morning and evening. The period of use was 2 weeks in winter.
上記の塗布期間終了後、インピーダンスメーター(I.B.
S.株式会社製、モデルI.B.355)を用いて試験部位の電
気伝導度を測定した。伝導度の値が大きい程角質層中の
水分量が多いことを示す。After the application period above, the impedance meter (IB
S. Co., Model IB355) was used to measure the electrical conductivity of the test site. The higher the conductivity value, the higher the water content in the stratum corneum.
判定は以下の如く各人について点数をつけることによっ
て行い、点数の総和を評価点として求めた。The judgment was made by assigning a score to each person as follows, and the sum of the scores was obtained as an evaluation point.
表2に、各ランクに判定された人数と、評価点とを示
す。 Table 2 shows the number of people judged in each rank and the evaluation points.
ii) 官能評価 20〜40才の乾燥肌の女性49名を被験者とし、各群7名計
7群として、各群1サンプルで実施例[1]及び比較例
[1]〜[6]の使用テストを行った。評価は、「肌へ
の弾力性賦与効果」、「しっとり効果」、「肌荒れ防止
効果」の三項目について、比較例[7]を対照とした相
対評価で行い、以下の如く点数をつけ、点数の総和を評
価点として求めた。 ii) Sensory evaluation 49 women with dry skin aged 20 to 40 years were used as subjects, 7 groups in each group, 7 groups in total, and 1 sample in each group was used in Example [1] and Comparative Examples [1] to [6]. I did a test. The evaluation was performed by relative evaluation with respect to the three items of "effect of imparting elasticity to skin", "moisturizing effect" and "effect of preventing rough skin" with Comparative Example [7] as a control, and scored as follows. Was calculated as the evaluation point.
表3に、各ランクに評価した人数と、評価点とを示す。 Table 3 shows the number of people evaluated in each rank and the evaluation points.
以上の評価結果から明らかな如く、実施例[1]の化粧
水は、ムコ多糖類、ビタミンE類、塩化ナトリウム、塩
化カリウム、塩化カルシウム、塩化マグネシウム、硫酸
マグネシウム、炭酸水素ナトリウム、リン酸水素二ナト
リウム、リン酸二水素ナトリウム、リン酸二水素カリウ
ムから選択される生理的塩類溶液を構成する混合無機塩
をそれぞれ単独、あるいは二種を組み合わせて配合した
場合と比較して顕著な保湿効果を示し、また、しっとり
感に富み、肌に弾力性を与え、肌荒れ防止効果も有する
という優れた皮膚の保護効果も有するものであった。 As is clear from the above evaluation results, the lotion of Example [1] contains mucopolysaccharides, vitamin Es, sodium chloride, potassium chloride, calcium chloride, magnesium chloride, magnesium sulfate, sodium hydrogen carbonate, and dihydrogen phosphate. It shows a remarkable moisturizing effect compared to the case where the mixed inorganic salts constituting the physiological salt solution selected from sodium, sodium dihydrogen phosphate and potassium dihydrogen phosphate are used alone or in combination of two kinds. In addition, it also has an excellent skin protecting effect that is rich in moist feeling, imparts elasticity to the skin, and has an effect of preventing rough skin.
実施例[2]化粧水 (処方) (重量%) (1) クエン酸 0.1 (2) クエン酸ナトリウム 0.2 (3) ピロリドンカルボン酸ナトリウム 0.5 (4) グリセリン 0.5 (5) ハマメリス抽出物 2.0 (6) ポリオキシエチレンポリオキシプロピレンセチ
ルエーテル(20E.O.,8P.O.) 0.5 (7) エチルアルコール 15.0 (8) パラオキシ安息香酸メチル 0.05 (9) 香料 0.1 (10) 酢酸dl−α−トコフェロール 0.05 (11) ヒアルロン酸 0.001 (12) エラスチン 0.01 (13) 塩化ナトリウム 0.65 (14) 塩化カリウム 0.014 (15) 塩化カルシウム 0.012 (16) 炭酸水素ナトリウム 0.02 (17) 精製水 残量 (製法) A (13)〜(16)を(17)に溶解する。Example [2] Lotion (prescription) (% by weight) (1) Citric acid 0.1 (2) Sodium citrate 0.2 (3) Sodium pyrrolidonecarboxylate 0.5 (4) Glycerin 0.5 (5) Hamamelis extract 2.0 (6) Polyoxyethylene polyoxypropylene cetyl ether (20E.O., 8P.O.) 0.5 (7) Ethyl alcohol 15.0 (8) Methyl paraoxybenzoate 0.05 (9) Perfume 0.1 (10) Acetic acid dl-α-tocopherol 0.05 ( 11) Hyaluronic acid 0.001 (12) Elastin 0.01 (13) Sodium chloride 0.65 (14) Potassium chloride 0.014 (15) Calcium chloride 0.012 (16) Sodium hydrogen carbonate 0.02 (17) Purified water residual amount (process) A (13) ~ Dissolve (16) in (17).
B (1)〜(5)、(11)、(12)をAに混合溶解す
る。B (1) to (5), (11) and (12) are mixed and dissolved in A.
C (6)〜(10)を混合溶解し、Bと混合する。C (6) to (10) are mixed and dissolved, and then mixed with B.
実施例[3]化粧水 (処方) (重量%) (1) クエン酸 0.1 (2) クエン酸ナトリウム 0.4 (3) 乳酸ナトリウム 0.8 (4) ピロリドンカルボン酸ナトリウム 0.8 (5) 1,3−ブチレングリコール 10.0 (6) ポリアクリル酸ナトリウム(0.5%水溶液)0.8
(7) モノオレイン酸ポリオキシエチレンソルビタン
(20E.O.) 0.2 (8) 香料 0.01 (9) 天然ビタミンE 0.1 (10) コンドロイチン硫酸ナトリウム 0.001 (11) コラーゲン 0.01 (12) 塩化ナトリウム 0.9 (13) 塩化カリウム 0.02 (14) 塩化カルシウム 0.02 (15) 塩化マグネシウム 0.005 (16) 炭酸水素ナトリウム 0.1 (17) リン酸二水素ナトリウム 0.004 (18) グルコース 0.1 (19) 精製水 残量 (製法) A (12)〜(18)を(19)に溶解する。Example [3] Lotion (prescription) (% by weight) (1) Citric acid 0.1 (2) Sodium citrate 0.4 (3) Sodium lactate 0.8 (4) Sodium pyrrolidonecarboxylate 0.8 (5) 1,3-Butylene glycol 10.0 (6) Sodium polyacrylate (0.5% aqueous solution) 0.8
(7) Polyoxyethylenesorbitan monooleate (20E.O.) 0.2 (8) Perfume 0.01 (9) Natural vitamin E 0.1 (10) Sodium chondroitin sulfate 0.001 (11) Collagen 0.01 (12) Sodium chloride 0.9 (13) Potassium chloride 0.02 (14) Calcium chloride 0.02 (15) Magnesium chloride 0.005 (16) Sodium hydrogen carbonate 0.1 (17) Sodium dihydrogen phosphate 0.004 (18) Glucose 0.1 (19) Purified water balance (production method) A (12) Dissolve ~ (18) in (19).
B (1)〜(6)、(10)、(11)をAに混合溶解す
る。B (1) to (6), (10) and (11) are mixed and dissolved in A.
C (7)〜(9)を混合溶解し、Bに加え、混合撹拌
する。C (7) to (9) are mixed and dissolved, added to B, and mixed and stirred.
実施例[4]カラミンローション (処方) (重量%) (1) 無水ケイ酸 0.35 (2) カオリン 0.2 (3) 酸化亜鉛 0.3 (4) 軽質炭酸カルシウム 0.9 (5) ベンガラ 0.002 (6) 1,3−ブチレングリコール 3.0 (7) エチルアルコール 12.0 (8) 香料 0.15 (9) ピロリドンカルボン酸 0.1 (10) α−トコフェロール 0.01 (11) ヒアルロン酸−蛋白複合体 0.01 (12) 塩化ナトリウム 0.9 (13) 塩化カリウム 0.042 (14) 塩化カルシウム 0.024 (15) 炭酸水素ナトリウム 0.02 (16) グルコース 0.1 (17) 精製水 残量 (製法) A (12)〜(16)を(17)に溶解する。Example [4] Calamine lotion (formulation) (% by weight) (1) Silicic anhydride 0.35 (2) Kaolin 0.2 (3) Zinc oxide 0.3 (4) Light calcium carbonate 0.9 (5) Bengal 0.002 (6) 1,3 -Butylene glycol 3.0 (7) Ethyl alcohol 12.0 (8) Perfume 0.15 (9) Pyrrolidonecarboxylic acid 0.1 (10) α-tocopherol 0.01 (11) Hyaluronic acid-protein complex 0.01 (12) Sodium chloride 0.9 (13) Potassium chloride 0.042 (14) Calcium chloride 0.024 (15) Sodium hydrogen carbonate 0.02 (16) Glucose 0.1 (17) Purified water Residual amount (production method) A (12) to (16) are dissolved in (17).
B (1)を(9)をAに混合撹拌する。B (1) is mixed with (9) in A and stirred.
C Bに(10)、(11)を添加し、さらに混合撹拌す
る。Add (10) and (11) to CB, and further mix and stir.
上記の如くして得られた実施例[2]〜[4]の化粧料
は、いずれも保湿効果に優れ、使用感も良いものであっ
た。The cosmetics of Examples [2] to [4] obtained as described above were all excellent in the moisturizing effect and had a good feeling in use.
[発明の効果] 以上詳述した如く、本発明は、ムコ多糖及び/又はその
誘導体と、ビタミンE及び/又はその誘導体と、塩化ナ
トリウム、塩化カリウム、塩化カルシウム、塩化マグネ
シウム、硫酸マグネシウム、炭酸水素ナトリウム、リン
酸水素二ナトリウム、リン酸二水素ナトリウム、リン酸
二水素カリウムから選択される生理的塩類溶液を構成す
る混合無機塩とを必須に含有することにより、これらの
成分の作用効果が相乗的に発揮された新規な化粧料を提
供するものである。[Effects of the Invention] As described in detail above, the present invention provides a mucopolysaccharide and / or a derivative thereof, vitamin E and / or a derivative thereof, sodium chloride, potassium chloride, calcium chloride, magnesium chloride, magnesium sulfate, hydrogen carbonate. By essentially containing a mixed inorganic salt that constitutes a physiological salt solution selected from sodium, disodium hydrogen phosphate, sodium dihydrogen phosphate, and potassium dihydrogen phosphate, the effects of these components are synergistic. It is intended to provide a new cosmetic material that is effectively exhibited.
すなわち、本発明により、従来になく顕著な保湿効果を
有し、皮膚の保護と水分の保持性に優れた、極めて有用
な化粧料の提供が可能となったのである。That is, according to the present invention, it has become possible to provide an extremely useful cosmetic composition which has an unprecedentedly remarkable moisturizing effect and is excellent in skin protection and water retention.
フロントページの続き (56)参考文献 特開 昭62−187406(JP,A) 特開 昭59−1404(JP,A) 特開 昭59−7106(JP,A) 特開 昭59−173125(JP,A) 特開 昭59−173124(JP,A) 特開 昭59−130206(JP,A) 特開 昭54−52733(JP,A) 蟇目浩吉外6編「ハンドブック−化粧 品・製剤原料−」(昭和52年)P.809− 817日光ケミカルズ株式会社外1発行Continuation of the front page (56) Reference JP 62-187406 (JP, A) JP 59-1404 (JP, A) JP 59-7106 (JP, A) JP 59-173125 (JP , A) JP-A-59-173124 (JP, A) JP-A-59-130206 (JP, A) JP-A-54-52733 (JP, A) H. Kimime et al. 6 Handbook-Cosmetics / Pharmaceutical Raw Materials- (Showa 52) P. 809-817 Published by Nikko Chemicals Co., Ltd. 1
Claims (1)
ンE及び/又はその誘導体と、塩化ナトリウム、塩化カ
リウム、塩化カルシウム、塩化マグネシウム、硫酸マグ
ネシウム、炭酸水素ナトリウム、リン酸水素二ナトリウ
ム、リン酸二水素ナトリウム、リン酸二水素カリウムか
ら選択される生理的塩類溶液を構成する混合無機塩とを
必須に含有することを特徴とする化粧料。1. A mucopolysaccharide and / or a derivative thereof, vitamin E and / or a derivative thereof, sodium chloride, potassium chloride, calcium chloride, magnesium chloride, magnesium sulfate, sodium hydrogen carbonate, disodium hydrogen phosphate, phosphoric acid. A cosmetic, which essentially contains a mixed inorganic salt constituting a physiological salt solution selected from sodium dihydrogen and potassium dihydrogen phosphate.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP61053372A JPH07121852B2 (en) | 1986-03-10 | 1986-03-10 | Cosmetics |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP61053372A JPH07121852B2 (en) | 1986-03-10 | 1986-03-10 | Cosmetics |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS62209009A JPS62209009A (en) | 1987-09-14 |
JPH07121852B2 true JPH07121852B2 (en) | 1995-12-25 |
Family
ID=12940980
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP61053372A Expired - Fee Related JPH07121852B2 (en) | 1986-03-10 | 1986-03-10 | Cosmetics |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH07121852B2 (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6339808A (en) * | 1986-08-05 | 1988-02-20 | Risuburan Prod:Kk | Cosmetic composition containing mineral components |
JPS63139104A (en) * | 1986-11-28 | 1988-06-10 | Kanebo Ltd | Skin cosmetic |
JP2769321B2 (en) * | 1988-03-18 | 1998-06-25 | 三省製薬株式会社 | External preparation |
JP2769341B2 (en) * | 1988-12-28 | 1998-06-25 | 三省製薬株式会社 | Stable external base composition |
JPH07291850A (en) * | 1994-04-26 | 1995-11-07 | Kanebo Ltd | Skin cosmetic |
JP4786630B2 (en) * | 2007-11-02 | 2011-10-05 | ロート製薬株式会社 | Topical skin preparation |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6019725B2 (en) * | 1977-10-04 | 1985-05-17 | ポ−ラ化成工業株式会社 | skin cosmetics |
JPS591404A (en) * | 1982-06-28 | 1984-01-06 | Shiseido Co Ltd | Emulsifiable composition |
JPS597106A (en) * | 1982-07-06 | 1984-01-14 | Shiseido Co Ltd | Emulsifiable composition |
JPS59130206A (en) * | 1982-12-28 | 1984-07-26 | Kobayashi Kooc:Kk | Preparation of cosmetic |
JPS59173124A (en) * | 1983-03-19 | 1984-10-01 | Shiseido Co Ltd | Emulsified composition |
JPS59173125A (en) * | 1983-03-19 | 1984-10-01 | Shiseido Co Ltd | Emulsified composition |
DE3327840C1 (en) * | 1983-08-02 | 1984-09-20 | Blendax Werke Schneider Co | Skin care products |
JPS60252405A (en) * | 1984-05-02 | 1985-12-13 | Kobayashi Kooc:Kk | Cosmetic |
JPS62187406A (en) * | 1986-02-13 | 1987-08-15 | Shiseido Co Ltd | W/o-type emulsified cosmetic |
-
1986
- 1986-03-10 JP JP61053372A patent/JPH07121852B2/en not_active Expired - Fee Related
Non-Patent Citations (1)
Title |
---|
蟇目浩吉外6編「ハンドブック−化粧品・製剤原料−」(昭和52年)P.809−817日光ケミカルズ株式会社外1発行 |
Also Published As
Publication number | Publication date |
---|---|
JPS62209009A (en) | 1987-09-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2113216C1 (en) | Cosmetic composition (versions) | |
CA2264877C (en) | Lip treatment containing live yeast cell derivative | |
JP3923226B2 (en) | Topical skin preparation | |
KR100377397B1 (en) | Skin care composition containing retinol and epidermal growth factor | |
JP3908126B2 (en) | Epidermal keratinization normalizing agent and skin external preparation containing the same | |
WO2018074642A1 (en) | Cosmetic composition for protecting lips, containing natural ceramides and rosehip oil as active ingredients | |
WO1997025050A1 (en) | Compositions containing vitamin d derivatives for treatment of photodamaged skin | |
JPH09183718A (en) | Composition suitable for external application | |
JPH07121852B2 (en) | Cosmetics | |
JPH07116010B2 (en) | Cosmetics | |
JPS60116618A (en) | Cosmetic | |
JP2000229835A (en) | Cosmetic material for improving dullness | |
CN104287982B (en) | Dandruff removal composition for adjusting oil balance of scalp | |
JP3507635B2 (en) | Composition suitable for external use | |
JP3104938B2 (en) | Cosmetics | |
JP2000109417A (en) | Cosmetic for improving somber color | |
JP2002145753A (en) | Heumectant composition and cosmetic including the same | |
JP3740069B2 (en) | Topical skin preparation | |
JPH03112912A (en) | Cosmetic composition | |
JPH082772B2 (en) | Sebum secretagogue | |
JP2002275027A (en) | Cosmetic and cosmetic impregnated in nonwoven fabric | |
JP2532495B2 (en) | Skin cosmetics | |
JPS6277308A (en) | Cosmetic | |
JPH03200708A (en) | Dermal external agent | |
JP2931083B2 (en) | Skin cosmetics |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |